Skip to content

CORT

Corcept Therapeutics Incorporated

Stock

$116.23+2.20 (+1.93%)Close Oct 2, 2026

Net income, 2025
$100M
YoY, 2025
−29.4%
5-year CAGR
−1.2%

Net income

Net income by fiscal year

PeriodNet incomeYoY
2025$100M−29.4%
2024$141M+33.0%
2023$106M+4.7%
2022$101M−9.9%
2021$113M+6.1%
2020$106M+12.6%
2019$94M+24.9%
2018$75M−41.6%
2017$129M+1,486.3%
2016$8.1M—
2015−$6.4M—
2014−$31M—
2013−$46M—
2012−$38M—
2011−$32M—
2010−$26M—
2009−$20M—
2008−$20M—
2007−$12M—
2006−$25M—
2005−$20M—
2004−$16M—
2003−$9.8M—
2002−$19M—
2001−$7.5M—
2000−$1.8M—